Lipopolysaccharide O structure of adherent and invasive Escherichia coli regulates intestinal inflammation via complement C3

Gut dysbiosis associated with intestinal inflammation is characterized by the blooming of particular bacteria such as adherent-invasive E. coli (AIEC). However, the precise mechanisms by which AIEC impact on colitis remain largely unknown. Here we show that antibiotic-induced dysbiosis worsened chem...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS pathogens 2020-10, Vol.16 (10), p.e1008928
Hauptverfasser: Ohno, Masashi, Hasegawa, Mizuho, Hayashi, Atsushi, Caballero-Flores, Gustavo, Alteri, Christopher J, Lawley, Trevor D, Kamada, Nobuhiko, Núñez, Gabriel, Inohara, Naohiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 10
container_start_page e1008928
container_title PLoS pathogens
container_volume 16
creator Ohno, Masashi
Hasegawa, Mizuho
Hayashi, Atsushi
Caballero-Flores, Gustavo
Alteri, Christopher J
Lawley, Trevor D
Kamada, Nobuhiko
Núñez, Gabriel
Inohara, Naohiro
description Gut dysbiosis associated with intestinal inflammation is characterized by the blooming of particular bacteria such as adherent-invasive E. coli (AIEC). However, the precise mechanisms by which AIEC impact on colitis remain largely unknown. Here we show that antibiotic-induced dysbiosis worsened chemically-induced colitis in IL-22-deficient mice, but not in wild-type mice. The increase in intestinal inflammation was associated with the expansion of E. coli strains with genetic and functional features of AIEC. These E. coli isolates exhibited high ability to out compete related bacteria via colicins and resistance to the host complement system in vitro. Mutation of wzy, the lipopolysaccharide O polymerase gene, rendered AIEC more sensitive to the complement system and more susceptible to engulfment and killing by phagocytes while retaining its ability to outcompete related bacteria in vitro. The wzy AIEC mutant showed impaired fitness to colonize the intestine under colitic conditions, but protected mice from chemically-induced colitis. Importantly, the ability of the wzy mutant to protect from colitis was blocked by depletion of complement C3 which was associated with impaired intestinal eradication of AIEC in colitic mice. These studies link surface lipopolysaccharide O-antigen structure to the regulation of colitic activity in commensal AIEC via interactions with the complement system.
doi_str_mv 10.1371/journal.ppat.1008928
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2460983404</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A645331652</galeid><doaj_id>oai_doaj_org_article_935f58dcefaf4743a79d47e153d71f71</doaj_id><sourcerecordid>A645331652</sourcerecordid><originalsourceid>FETCH-LOGICAL-c661t-8d7bf061c4519986f1c2157708babc1e4bd7bb14707d2ada1452db9649a052953</originalsourceid><addsrcrecordid>eNqVkl2L1DAUhoso7rr6D0QLe-XFjEmTNO2NsAyrDgwu-HEdTvPRydA2NUkHF_zxZna6yw7ohQSScPKcNydvTpa9xmiJCcfvd27yA3TLcYS4xAhVdVE9yc4xY2TBCadPH-3Pshch7BCimODyeXZGCCp4UaHz7PfGjm503W0AKbfgrdL5TR6in2ScvM6dyUFttddDzGFQuR32EOxe59dBprCVWwu5dJ3NvW6nDqIOiUlztKm4tDUd9D1E64Z8f4f2Y6f7g9yKvMyeGeiCfjWvF9mPj9ffV58Xm5tP69XVZiHLEsdFpXhjUIklZbiuq9JgWWDGOaoaaCTWtElAgylHXBWgAFNWqKYuaQ2IFTUjF9nbo-7YuSBm44IoaInqilBEE7E-EsrBToze9uBvhQMr7gLOtwJ8tLLToibMsEpJbcBQTgnwWlGuMSOKY8Nx0vow3zY1vU7gED10J6KnJ4PditbtBWcclxVPApezgHc_p2TlP0qeqRZSVclol8Rkb4MUVyVlJP00KxK1_AuVhtK9lW7Qxqb4ScK7k4TERP0rtjCFINbfvv4H--WUpUdWeheC1-bBEIzEoaHvHykODS3mhk5pbx6b-ZB038HkD3D28zE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2460983404</pqid></control><display><type>article</type><title>Lipopolysaccharide O structure of adherent and invasive Escherichia coli regulates intestinal inflammation via complement C3</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><source>Public Library of Science (PLoS)</source><creator>Ohno, Masashi ; Hasegawa, Mizuho ; Hayashi, Atsushi ; Caballero-Flores, Gustavo ; Alteri, Christopher J ; Lawley, Trevor D ; Kamada, Nobuhiko ; Núñez, Gabriel ; Inohara, Naohiro</creator><creatorcontrib>Ohno, Masashi ; Hasegawa, Mizuho ; Hayashi, Atsushi ; Caballero-Flores, Gustavo ; Alteri, Christopher J ; Lawley, Trevor D ; Kamada, Nobuhiko ; Núñez, Gabriel ; Inohara, Naohiro</creatorcontrib><description>Gut dysbiosis associated with intestinal inflammation is characterized by the blooming of particular bacteria such as adherent-invasive E. coli (AIEC). However, the precise mechanisms by which AIEC impact on colitis remain largely unknown. Here we show that antibiotic-induced dysbiosis worsened chemically-induced colitis in IL-22-deficient mice, but not in wild-type mice. The increase in intestinal inflammation was associated with the expansion of E. coli strains with genetic and functional features of AIEC. These E. coli isolates exhibited high ability to out compete related bacteria via colicins and resistance to the host complement system in vitro. Mutation of wzy, the lipopolysaccharide O polymerase gene, rendered AIEC more sensitive to the complement system and more susceptible to engulfment and killing by phagocytes while retaining its ability to outcompete related bacteria in vitro. The wzy AIEC mutant showed impaired fitness to colonize the intestine under colitic conditions, but protected mice from chemically-induced colitis. Importantly, the ability of the wzy mutant to protect from colitis was blocked by depletion of complement C3 which was associated with impaired intestinal eradication of AIEC in colitic mice. These studies link surface lipopolysaccharide O-antigen structure to the regulation of colitic activity in commensal AIEC via interactions with the complement system.</description><identifier>ISSN: 1553-7374</identifier><identifier>ISSN: 1553-7366</identifier><identifier>EISSN: 1553-7374</identifier><identifier>DOI: 10.1371/journal.ppat.1008928</identifier><identifier>PMID: 33027280</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Animals ; Antibiotics ; Antigens ; Bacteria ; Bacterial Adhesion - drug effects ; Bacterial Adhesion - physiology ; Bacterial infections ; Biology and Life Sciences ; Care and treatment ; Colicins ; Colitis ; Colon ; Complement ; Complement C3 - metabolism ; Complement component C3 ; Complement system ; Correlation analysis ; Crohn Disease - microbiology ; Cytokines ; Depletion ; Development and progression ; Dysbacteriosis ; Dysbiosis ; E coli ; Escherichia coli - drug effects ; Escherichia coli - genetics ; Escherichia coli infections ; Escherichia coli Infections - drug therapy ; Escherichia coli Infections - microbiology ; Feces ; Funding ; Health aspects ; Host-bacteria relationships ; Immune system ; Inflammation ; Inflammation - microbiology ; Inflammatory bowel disease ; Interleukin 22 ; Internal medicine ; Intestinal Mucosa - microbiology ; Intestine ; Lipopolysaccharides ; Lipopolysaccharides - chemistry ; Lipopolysaccharides - pharmacology ; Medical schools ; Medicine and Health Sciences ; Mice, Inbred C57BL ; Microbiota ; Microorganisms ; Mutants ; Mutation ; Pathology ; Phagocytes ; Rodents</subject><ispartof>PLoS pathogens, 2020-10, Vol.16 (10), p.e1008928</ispartof><rights>COPYRIGHT 2020 Public Library of Science</rights><rights>2020 Ohno et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 Ohno et al 2020 Ohno et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c661t-8d7bf061c4519986f1c2157708babc1e4bd7bb14707d2ada1452db9649a052953</citedby><cites>FETCH-LOGICAL-c661t-8d7bf061c4519986f1c2157708babc1e4bd7bb14707d2ada1452db9649a052953</cites><orcidid>0000-0002-4108-2773 ; 0000-0002-4215-9349 ; 0000-0002-1980-4178 ; 0000-0003-3505-7835 ; 0000-0002-6367-5684 ; 0000-0002-6529-2695 ; 0000-0003-4060-2383</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571687/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571687/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79343,79344</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33027280$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ohno, Masashi</creatorcontrib><creatorcontrib>Hasegawa, Mizuho</creatorcontrib><creatorcontrib>Hayashi, Atsushi</creatorcontrib><creatorcontrib>Caballero-Flores, Gustavo</creatorcontrib><creatorcontrib>Alteri, Christopher J</creatorcontrib><creatorcontrib>Lawley, Trevor D</creatorcontrib><creatorcontrib>Kamada, Nobuhiko</creatorcontrib><creatorcontrib>Núñez, Gabriel</creatorcontrib><creatorcontrib>Inohara, Naohiro</creatorcontrib><title>Lipopolysaccharide O structure of adherent and invasive Escherichia coli regulates intestinal inflammation via complement C3</title><title>PLoS pathogens</title><addtitle>PLoS Pathog</addtitle><description>Gut dysbiosis associated with intestinal inflammation is characterized by the blooming of particular bacteria such as adherent-invasive E. coli (AIEC). However, the precise mechanisms by which AIEC impact on colitis remain largely unknown. Here we show that antibiotic-induced dysbiosis worsened chemically-induced colitis in IL-22-deficient mice, but not in wild-type mice. The increase in intestinal inflammation was associated with the expansion of E. coli strains with genetic and functional features of AIEC. These E. coli isolates exhibited high ability to out compete related bacteria via colicins and resistance to the host complement system in vitro. Mutation of wzy, the lipopolysaccharide O polymerase gene, rendered AIEC more sensitive to the complement system and more susceptible to engulfment and killing by phagocytes while retaining its ability to outcompete related bacteria in vitro. The wzy AIEC mutant showed impaired fitness to colonize the intestine under colitic conditions, but protected mice from chemically-induced colitis. Importantly, the ability of the wzy mutant to protect from colitis was blocked by depletion of complement C3 which was associated with impaired intestinal eradication of AIEC in colitic mice. These studies link surface lipopolysaccharide O-antigen structure to the regulation of colitic activity in commensal AIEC via interactions with the complement system.</description><subject>Animals</subject><subject>Antibiotics</subject><subject>Antigens</subject><subject>Bacteria</subject><subject>Bacterial Adhesion - drug effects</subject><subject>Bacterial Adhesion - physiology</subject><subject>Bacterial infections</subject><subject>Biology and Life Sciences</subject><subject>Care and treatment</subject><subject>Colicins</subject><subject>Colitis</subject><subject>Colon</subject><subject>Complement</subject><subject>Complement C3 - metabolism</subject><subject>Complement component C3</subject><subject>Complement system</subject><subject>Correlation analysis</subject><subject>Crohn Disease - microbiology</subject><subject>Cytokines</subject><subject>Depletion</subject><subject>Development and progression</subject><subject>Dysbacteriosis</subject><subject>Dysbiosis</subject><subject>E coli</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - genetics</subject><subject>Escherichia coli infections</subject><subject>Escherichia coli Infections - drug therapy</subject><subject>Escherichia coli Infections - microbiology</subject><subject>Feces</subject><subject>Funding</subject><subject>Health aspects</subject><subject>Host-bacteria relationships</subject><subject>Immune system</subject><subject>Inflammation</subject><subject>Inflammation - microbiology</subject><subject>Inflammatory bowel disease</subject><subject>Interleukin 22</subject><subject>Internal medicine</subject><subject>Intestinal Mucosa - microbiology</subject><subject>Intestine</subject><subject>Lipopolysaccharides</subject><subject>Lipopolysaccharides - chemistry</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Medical schools</subject><subject>Medicine and Health Sciences</subject><subject>Mice, Inbred C57BL</subject><subject>Microbiota</subject><subject>Microorganisms</subject><subject>Mutants</subject><subject>Mutation</subject><subject>Pathology</subject><subject>Phagocytes</subject><subject>Rodents</subject><issn>1553-7374</issn><issn>1553-7366</issn><issn>1553-7374</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqVkl2L1DAUhoso7rr6D0QLe-XFjEmTNO2NsAyrDgwu-HEdTvPRydA2NUkHF_zxZna6yw7ohQSScPKcNydvTpa9xmiJCcfvd27yA3TLcYS4xAhVdVE9yc4xY2TBCadPH-3Pshch7BCimODyeXZGCCp4UaHz7PfGjm503W0AKbfgrdL5TR6in2ScvM6dyUFttddDzGFQuR32EOxe59dBprCVWwu5dJ3NvW6nDqIOiUlztKm4tDUd9D1E64Z8f4f2Y6f7g9yKvMyeGeiCfjWvF9mPj9ffV58Xm5tP69XVZiHLEsdFpXhjUIklZbiuq9JgWWDGOaoaaCTWtElAgylHXBWgAFNWqKYuaQ2IFTUjF9nbo-7YuSBm44IoaInqilBEE7E-EsrBToze9uBvhQMr7gLOtwJ8tLLToibMsEpJbcBQTgnwWlGuMSOKY8Nx0vow3zY1vU7gED10J6KnJ4PditbtBWcclxVPApezgHc_p2TlP0qeqRZSVclol8Rkb4MUVyVlJP00KxK1_AuVhtK9lW7Qxqb4ScK7k4TERP0rtjCFINbfvv4H--WUpUdWeheC1-bBEIzEoaHvHykODS3mhk5pbx6b-ZB038HkD3D28zE</recordid><startdate>20201007</startdate><enddate>20201007</enddate><creator>Ohno, Masashi</creator><creator>Hasegawa, Mizuho</creator><creator>Hayashi, Atsushi</creator><creator>Caballero-Flores, Gustavo</creator><creator>Alteri, Christopher J</creator><creator>Lawley, Trevor D</creator><creator>Kamada, Nobuhiko</creator><creator>Núñez, Gabriel</creator><creator>Inohara, Naohiro</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISN</scope><scope>ISR</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4108-2773</orcidid><orcidid>https://orcid.org/0000-0002-4215-9349</orcidid><orcidid>https://orcid.org/0000-0002-1980-4178</orcidid><orcidid>https://orcid.org/0000-0003-3505-7835</orcidid><orcidid>https://orcid.org/0000-0002-6367-5684</orcidid><orcidid>https://orcid.org/0000-0002-6529-2695</orcidid><orcidid>https://orcid.org/0000-0003-4060-2383</orcidid></search><sort><creationdate>20201007</creationdate><title>Lipopolysaccharide O structure of adherent and invasive Escherichia coli regulates intestinal inflammation via complement C3</title><author>Ohno, Masashi ; Hasegawa, Mizuho ; Hayashi, Atsushi ; Caballero-Flores, Gustavo ; Alteri, Christopher J ; Lawley, Trevor D ; Kamada, Nobuhiko ; Núñez, Gabriel ; Inohara, Naohiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c661t-8d7bf061c4519986f1c2157708babc1e4bd7bb14707d2ada1452db9649a052953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Antibiotics</topic><topic>Antigens</topic><topic>Bacteria</topic><topic>Bacterial Adhesion - drug effects</topic><topic>Bacterial Adhesion - physiology</topic><topic>Bacterial infections</topic><topic>Biology and Life Sciences</topic><topic>Care and treatment</topic><topic>Colicins</topic><topic>Colitis</topic><topic>Colon</topic><topic>Complement</topic><topic>Complement C3 - metabolism</topic><topic>Complement component C3</topic><topic>Complement system</topic><topic>Correlation analysis</topic><topic>Crohn Disease - microbiology</topic><topic>Cytokines</topic><topic>Depletion</topic><topic>Development and progression</topic><topic>Dysbacteriosis</topic><topic>Dysbiosis</topic><topic>E coli</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - genetics</topic><topic>Escherichia coli infections</topic><topic>Escherichia coli Infections - drug therapy</topic><topic>Escherichia coli Infections - microbiology</topic><topic>Feces</topic><topic>Funding</topic><topic>Health aspects</topic><topic>Host-bacteria relationships</topic><topic>Immune system</topic><topic>Inflammation</topic><topic>Inflammation - microbiology</topic><topic>Inflammatory bowel disease</topic><topic>Interleukin 22</topic><topic>Internal medicine</topic><topic>Intestinal Mucosa - microbiology</topic><topic>Intestine</topic><topic>Lipopolysaccharides</topic><topic>Lipopolysaccharides - chemistry</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Medical schools</topic><topic>Medicine and Health Sciences</topic><topic>Mice, Inbred C57BL</topic><topic>Microbiota</topic><topic>Microorganisms</topic><topic>Mutants</topic><topic>Mutation</topic><topic>Pathology</topic><topic>Phagocytes</topic><topic>Rodents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ohno, Masashi</creatorcontrib><creatorcontrib>Hasegawa, Mizuho</creatorcontrib><creatorcontrib>Hayashi, Atsushi</creatorcontrib><creatorcontrib>Caballero-Flores, Gustavo</creatorcontrib><creatorcontrib>Alteri, Christopher J</creatorcontrib><creatorcontrib>Lawley, Trevor D</creatorcontrib><creatorcontrib>Kamada, Nobuhiko</creatorcontrib><creatorcontrib>Núñez, Gabriel</creatorcontrib><creatorcontrib>Inohara, Naohiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Canada</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PLoS pathogens</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohno, Masashi</au><au>Hasegawa, Mizuho</au><au>Hayashi, Atsushi</au><au>Caballero-Flores, Gustavo</au><au>Alteri, Christopher J</au><au>Lawley, Trevor D</au><au>Kamada, Nobuhiko</au><au>Núñez, Gabriel</au><au>Inohara, Naohiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lipopolysaccharide O structure of adherent and invasive Escherichia coli regulates intestinal inflammation via complement C3</atitle><jtitle>PLoS pathogens</jtitle><addtitle>PLoS Pathog</addtitle><date>2020-10-07</date><risdate>2020</risdate><volume>16</volume><issue>10</issue><spage>e1008928</spage><pages>e1008928-</pages><issn>1553-7374</issn><issn>1553-7366</issn><eissn>1553-7374</eissn><abstract>Gut dysbiosis associated with intestinal inflammation is characterized by the blooming of particular bacteria such as adherent-invasive E. coli (AIEC). However, the precise mechanisms by which AIEC impact on colitis remain largely unknown. Here we show that antibiotic-induced dysbiosis worsened chemically-induced colitis in IL-22-deficient mice, but not in wild-type mice. The increase in intestinal inflammation was associated with the expansion of E. coli strains with genetic and functional features of AIEC. These E. coli isolates exhibited high ability to out compete related bacteria via colicins and resistance to the host complement system in vitro. Mutation of wzy, the lipopolysaccharide O polymerase gene, rendered AIEC more sensitive to the complement system and more susceptible to engulfment and killing by phagocytes while retaining its ability to outcompete related bacteria in vitro. The wzy AIEC mutant showed impaired fitness to colonize the intestine under colitic conditions, but protected mice from chemically-induced colitis. Importantly, the ability of the wzy mutant to protect from colitis was blocked by depletion of complement C3 which was associated with impaired intestinal eradication of AIEC in colitic mice. These studies link surface lipopolysaccharide O-antigen structure to the regulation of colitic activity in commensal AIEC via interactions with the complement system.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>33027280</pmid><doi>10.1371/journal.ppat.1008928</doi><orcidid>https://orcid.org/0000-0002-4108-2773</orcidid><orcidid>https://orcid.org/0000-0002-4215-9349</orcidid><orcidid>https://orcid.org/0000-0002-1980-4178</orcidid><orcidid>https://orcid.org/0000-0003-3505-7835</orcidid><orcidid>https://orcid.org/0000-0002-6367-5684</orcidid><orcidid>https://orcid.org/0000-0002-6529-2695</orcidid><orcidid>https://orcid.org/0000-0003-4060-2383</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1553-7374
ispartof PLoS pathogens, 2020-10, Vol.16 (10), p.e1008928
issn 1553-7374
1553-7366
1553-7374
language eng
recordid cdi_plos_journals_2460983404
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access; Public Library of Science (PLoS)
subjects Animals
Antibiotics
Antigens
Bacteria
Bacterial Adhesion - drug effects
Bacterial Adhesion - physiology
Bacterial infections
Biology and Life Sciences
Care and treatment
Colicins
Colitis
Colon
Complement
Complement C3 - metabolism
Complement component C3
Complement system
Correlation analysis
Crohn Disease - microbiology
Cytokines
Depletion
Development and progression
Dysbacteriosis
Dysbiosis
E coli
Escherichia coli - drug effects
Escherichia coli - genetics
Escherichia coli infections
Escherichia coli Infections - drug therapy
Escherichia coli Infections - microbiology
Feces
Funding
Health aspects
Host-bacteria relationships
Immune system
Inflammation
Inflammation - microbiology
Inflammatory bowel disease
Interleukin 22
Internal medicine
Intestinal Mucosa - microbiology
Intestine
Lipopolysaccharides
Lipopolysaccharides - chemistry
Lipopolysaccharides - pharmacology
Medical schools
Medicine and Health Sciences
Mice, Inbred C57BL
Microbiota
Microorganisms
Mutants
Mutation
Pathology
Phagocytes
Rodents
title Lipopolysaccharide O structure of adherent and invasive Escherichia coli regulates intestinal inflammation via complement C3
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T17%3A04%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lipopolysaccharide%20O%20structure%20of%20adherent%20and%20invasive%20Escherichia%20coli%20regulates%20intestinal%20inflammation%20via%20complement%20C3&rft.jtitle=PLoS%20pathogens&rft.au=Ohno,%20Masashi&rft.date=2020-10-07&rft.volume=16&rft.issue=10&rft.spage=e1008928&rft.pages=e1008928-&rft.issn=1553-7374&rft.eissn=1553-7374&rft_id=info:doi/10.1371/journal.ppat.1008928&rft_dat=%3Cgale_plos_%3EA645331652%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2460983404&rft_id=info:pmid/33027280&rft_galeid=A645331652&rft_doaj_id=oai_doaj_org_article_935f58dcefaf4743a79d47e153d71f71&rfr_iscdi=true